Amplimed Corporation is categorized under Commercial Medical Research in Tucson, AZ and active since 2003.
Amplimed Corporation was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Robert A Ashley at the company’s single location by writing to 4380 North Campbell Avenue # 204, Tucson, Arizona AZ 85718 or by phoning (817) 466-9652. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amplimed Corporation |
| Contact Person: | Robert A Ashley |
| Address: | 4380 North Campbell Avenue # 204, Tucson, Arizona 85718 |
| Phone Number: | (817) 466-9652 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Amplimed Corporation was started in 2003 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert A Ashley for inquiries that concern Amplimed Corporation by calling the company number (817) 466-9652, as your correspondence is most welcome. Additionally, the physical location of the single location of Amplimed Corporation can be found at the coordinates 32.286806,-110.943703 as well as the street address 4380 North Campbell Avenue # 204 in Tucson, Arizona 85718.
For its online presence, you may visit Amplimed Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.